fbpx Skip to main content

Webinar: Clinical Trials in the Era of COVID-19: Insights from the FDA


August 11, 2020 9:00 amAugust 11, 2020 10:00 am (PDT)


Live Webinar – You will receive webinar link via email prior to the event.



Biocom, in partnership with the Food & Drug Administration (FDA), is hosting a webinar on conducting clinical trials during the ongoing COVID-19 pandemic.

The pandemic has disrupted the operations of many biotechnology and pharmaceutical companies. The life science industry is searching for clarity and strategies on how to address the challenges presented by the COVID-19 outbreak. The pandemic has forced many companies to make difficult decisions to pause ongoing trials and reconsider timelines for data readouts, regulatory reviews, and product launches due to impaired access to the healthcare system, travel restrictions, patient willingness to participate in trials and shifts in resources to fight the pandemic.

Join us as we receive insight from:
• Jacqueline Corrigan-Curay JD, MD, Director, Office of Medical Policy (OMP)
• James Smith, MD, Deputy Director, Office of New Drugs (OND), Division Clinical Policy
• Paul Kluetz, MD, Deputy Director, Oncology Center of Excellence (OCE)

This webinar will address members’ concerns on the impact of COVID-19 in the following areas:
• Inform Consent Forms (ICFs)
• Protocol Deviations
• Benefit/Risk Assessments
• Adverse Events Reporting
• Clinical Study Reports (CSRs)
• Compassionate Treatments
• Emergency Approvals
• Cancer Screenings

*There will not be a Q&A. We have submitted questions in advanced to the speakers.

Price of Admission

Biocom Member

Today’s Price: 0

Important Dates


Registration before

Registration before

Registration before

Registration cost


Refund before 2020-08-11


Refund before

Refund Before